With The Multitude of Benefits That ePRO Provides, Why Are Clinical Trials Still Using Paper? Essential Tips for Making The Switch
Although some have incorporated electronic Paper Reported Outcomes (ePRO) and electronic Clinical Outcome Assessments (eCOA) in their protocol designs, many continue to use paper-based PROs / COAs. This article will provide you with insight into the time- and cost-saving benefits realized when transferring from paper to ePRO / eCOA.
you will learn:
- What kind of guidance the FDA offers
- Patient preferences and trends
- Considerations for successful ePRO integration plans
Free Instant Access
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to [email protected]. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.